Cargando…
Poly(l-glutamic acid)-cisplatin nanoformulations with detachable PEGylation for prolonged circulation half-life and enhanced cell internalization
PEGylation has been widely applied to prolong the circulation times of nanomedicines via the steric shielding effect, which consequently improves the intratumoral accumulation. However, cell uptake of PEGylated nanoformulations is always blocked by the steric repulsion of PEG, which limits their the...
Autores principales: | Jiang, Zhongyu, Feng, Xiangru, Zou, Haoyang, Xu, Weiguo, Zhuang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895728/ https://www.ncbi.nlm.nih.gov/pubmed/33665501 http://dx.doi.org/10.1016/j.bioactmat.2021.01.034 |
Ejemplares similares
-
PEGylated Polyurea Bearing Hindered Urea Bond for Drug Delivery
por: Chen, Meishan, et al.
Publicado: (2019) -
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2022) -
Poly Lactic-Co-Glycolic Acid- (PLGA-) Loaded Nanoformulation of Cisplatin as a Therapeutic Approach for Breast Cancers
por: Alkahtani, Saad, et al.
Publicado: (2021) -
PEGylation Prolongs the Half-Life of Equine Anti-SARS-CoV-2 Specific F(ab’)(2)
por: Xu, Mengyuan, et al.
Publicado: (2023) -
Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats
por: Özcan, İpek, et al.
Publicado: (2010)